You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Waldenstrom Macroglobulinemia, Ibrutinib, Bortezomib

Showing 1 - 25 of 1,175
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenstrom Macroglobulinemia Trial in Germany, Greece (Ibrutinib / Bortezomib / Rituximab)

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • Ibrutinib / Bortezomib / Rituximab
  • Berlin, Germany
  • +14 more
Mar 7, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)

Completed
Has Results
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
  • +1 more
Dec 5, 2022

Waldenstrom Macroglobulinemia Trial in China (Ibrutinib)

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • Changchun, China
  • +5 more
Jan 27, 2023

Waldenstrom's Macroglobulinemia Trial in Houston (Bortezomib, Rituximab, Valacyclovir)

Active, not recruiting
Has Results
  • Waldenstrom's Macroglobulinemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Ulocuplumab, Ibrutinib)

Active, not recruiting
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 20, 2022

Waldenstrom Macroglobulinemia Trial in Japan (Ibrutinib, Rituximab)

Active, not recruiting
Has Results
  • Waldenstrom Macroglobulinemia
  • Chiba, Japan
  • +8 more
Jan 27, 2023

Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • MYD88 Gene Mutation
  • Boston, Massachusetts
  • +1 more
Apr 1, 2022

Waldenström's Macroglobulinemia Trial in Ulm (Dexamethasone, Rituximab, Cyclophosphamide, Dexamethasone, Rituximab,

Active, not recruiting
  • Waldenström's Macroglobulinemia
  • Dexamethasone, Rituximab, Cyclophosphamide
  • Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib
  • Ulm, Germany
    University Hospital Ulm
May 26, 2022

Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • DASATINIB
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Waldenstrom Macroglobulinemia, Waldenstrom's Disease, Waldenström; Hypergammaglobulinemia Trial in New York (Ibrutinib,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +6 more
  • New York, New York
    Weill Cornell Medicine
Dec 21, 2021

Waldenstrom Macroglobulinemia Trial in Austria, Germany, Greece (Carfilzomib + Ibrutinib, Ibrutinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Salzburg, Austria
  • +16 more
Mar 11, 2022

Waldenström's Macroglobulinemia Trial in Busan (Lenalidomide, Bortezomib, Rituximab, Dexamethasone)

Recruiting
  • Waldenström's Macroglobulinemia
  • Lenalidomide, Bortezomib, Rituximab, Dexamethasone
  • Busan, Sue-gu, Korea, Republic of
    Kosin University Gospel Hospital
Mar 31, 2022

Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,

Withdrawn
  • Asymptomatic COVID-19 Infection Laboratory-Confirmed
  • +8 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 2, 2022

Waldenstrom's Macroglobulinemia Trial in Athens, Rotterdam, Salamanca (Bortezomib, Rituximab, Dexamethasone)

Completed
  • Waldenstrom's Macroglobulinemia
  • Bortezomib, Rituximab, Dexamethasone
  • Athens, Attica, Greece
  • +3 more
Apr 27, 2021

Waldenstrom's Macroglobulinemia Trial in Boston (Everolimus, Rituximab, Bortezomib)

Terminated
Has Results
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Apr 22, 2021

Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Zanubrutinib, Bendamustine and Rituximab
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jun 13, 2023

Waldenström's Macroglobulinemia Trial in Worldwide (BGB-3111, Ibrutinib)

Completed
  • Waldenström's Macroglobulinemia
  • Phoenix, Arizona
  • +79 more
Jul 6, 2022

Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia Trial in United States (Ibrutinib, Rituximab, Venetoclax)

Suspended
  • Lymphoplasmacytic Lymphoma
  • Waldenstrom Macroglobulinemia
  • Centralia, Illinois
  • +73 more
Jul 27, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of

Active, not recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +22 more
  • Scottsdale, Arizona
  • +1 more
Aug 10, 2021

Waldenstrom's Macroglobulinemia Trial in Boston (Bortezomib, Rituximab)

Completed
Has Results
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Oct 6, 2020

Waldenstrom's Macroglobulinemia Trial in Italy (Bortezomib-Rituximab-Bendamustine)

Completed
  • Waldenstrom's Macroglobulinemia
  • Messina, ME, Italy
  • +22 more
Dec 1, 2020

Waldenstrom Macroglobulinemia Trial in United Kingdom (Dexamethasone, cyclophosphamide, rituximab, Rituximab, ibrutinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Dexamethasone, cyclophosphamide, rituximab
  • Rituximab, ibrutinib
  • Bournemouth, United Kingdom
  • +6 more
Dec 16, 2020

Waldenström's Macroglobulinemia Trial in Worldwide (Ibrutinib, Placebo, Rituximab)

Completed
Has Results
  • Waldenström's Macroglobulinemia
  • Los Angeles, California
  • +47 more
Feb 9, 2021

Waldenstrom's Macroglobulinaemia Trial in United Kingdom (Bortezomib, Cyclophosphamide, Rituximab)

Completed
  • Waldenstrom's Macroglobulinaemia
  • Basingstoke, United Kingdom
  • +29 more
Jun 17, 2021

Waldenstrom Macroglobulinemia Trial (Venetoclax; Rituximab, DRC)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • Venetoclax; Rituximab
  • DRC
  • (no location specified)
Nov 4, 2022